Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH SUVEN LIFE SCIENCES PROCTER & GAMBLE HEALTH/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 35.5 -21.1 - View Chart
P/BV x 10.8 6.0 181.7% View Chart
Dividend Yield % 2.0 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
SUVEN LIFE SCIENCES
Mar-23
PROCTER & GAMBLE HEALTH/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs5,36694 5,722.7%   
Low Rs3,88345 8,627.0%   
Sales per share (Unadj.) Rs740.70.6 119,308.7%  
Earnings per share (Unadj.) Rs138.2-5.4 -2,548.9%  
Cash flow per share (Unadj.) Rs155.2-5.1 -3,028.5%  
Dividends per share (Unadj.) Rs95.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs447.617.2 2,600.8%  
Shares outstanding (eoy) m16.60218.07 7.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.2111.8 5.6%   
Avg P/E ratio x33.5-12.8 -261.5%  
P/CF ratio (eoy) x29.8-13.5 -220.1%  
Price / Book Value ratio x10.34.0 256.2%  
Dividend payout %68.70-   
Avg Mkt Cap Rs m76,76115,131 507.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,062186 1,107.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,296135 9,082.1%  
Other income Rs m18484 217.7%   
Total revenues Rs m12,480220 5,675.9%   
Gross profit Rs m3,247-1,196 -271.4%  
Depreciation Rs m28165 429.5%   
Interest Rs m85 143.1%   
Profit before tax Rs m3,142-1,183 -265.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8470-   
Profit after tax Rs m2,295-1,183 -194.0%  
Gross profit margin %26.4-883.6 -3.0%  
Effective tax rate %27.00-   
Net profit margin %18.7-873.5 -2.1%  
BALANCE SHEET DATA
Current assets Rs m11,7133,455 339.0%   
Current liabilities Rs m6,7911,050 646.6%   
Net working cap to sales %40.01,776.0 2.3%  
Current ratio x1.73.3 52.4%  
Inventory Days Days2633,948 6.7%  
Debtors Days Days343218 157.8%  
Net fixed assets Rs m10,6171,373 773.1%   
Share capital Rs m166218 76.1%   
"Free" reserves Rs m7,2653,535 205.5%   
Net worth Rs m7,4313,753 198.0%   
Long term debt Rs m00-   
Total assets Rs m22,3304,828 462.5%  
Interest coverage x409.1-218.8 -186.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60 1,963.7%   
Return on assets %10.3-24.4 -42.3%  
Return on equity %30.9-31.5 -98.0%  
Return on capital %42.4-31.4 -135.1%  
Exports to sales %040.4 0.0%   
Imports to sales %13.1839.8 1.6%   
Exports (fob) Rs mNA55 0.0%   
Imports (cif) Rs m1,6051,137 141.2%   
Fx inflow Rs m1,46555 2,676.2%   
Fx outflow Rs m1,6051,137 141.2%   
Net fx Rs m-140-1,082 13.0%   
CASH FLOW
From Operations Rs m2,360-1,031 -228.8%  
From Investments Rs m-215-2,606 8.2%  
From Financial Activity Rs m-9853,955 -24.9%  
Net Cashflow Rs m1,160317 365.5%  

Share Holding

Indian Promoters % 0.0 69.6 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 0.6 3,683.6%  
FIIs % 7.6 0.5 1,407.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 30.4 158.3%  
Shareholders   56,730 74,003 76.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Suven Life Sciences Share Price Performance

Period Procter & Gamble Health Suven Life Sciences S&P BSE HEALTHCARE
1-Day -0.89% -0.68% -1.08%
1-Month -3.68% -7.70% -5.13%
1-Year -1.45% 113.56% 57.29%
3-Year CAGR -9.03% 14.14% 18.10%
5-Year CAGR 7.91% -15.24% 18.85%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.